Effects of Cardiac Rehabilitation on High Mobility Group Box-1 Levels After Acute Myocardial Infarction

This study has been completed.
Sponsor:
Information provided by:
Federico II University
ClinicalTrials.gov Identifier:
NCT00755131
First received: September 17, 2008
Last updated: January 25, 2010
Last verified: December 2009
Results First Received: November 5, 2009  
Study Type: Interventional
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Single Blind (Investigator);   Primary Purpose: Basic Science
Condition: Acute Myocardial Infarction
Intervention: Other: Exercise-based Cardiac Rehabilitation program

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
This study was a single-center, randomized, controlled study carried out from October 2008 to January 2009 at the Department of Clinical Medicine, Cardiovascular and Immunological Sciences, University of Naples “Federico II”.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Exercise Training Group Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program
Control Group Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program.

Participant Flow:   Overall Study
    Exercise Training Group     Control Group  
STARTED     37     38  
COMPLETED     37     38  
NOT COMPLETED     0     0  



  Baseline Characteristics
  Hide Baseline Characteristics

Reporting Groups
  Description
Exercise Training Group Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program
Control Group Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program.
Total Total of all reporting groups

Baseline Measures
    Exercise Training Group     Control Group     Total  
Number of Participants  
[units: participants]
  37     38     75  
Age  
[units: participants]
     
<=18 years     0     0     0  
Between 18 and 65 years     28     29     57  
>=65 years     9     9     18  
Age  
[units: years]
Mean ± Standard Deviation
  60.8  ± 7.0     59.5  ± 7.7     60.4  ± 7.5  
Gender  
[units: participants]
     
Female     9     6     15  
Male     28     32     60  
Region of Enrollment  
[units: participants]
     
Italy     37     38     75  



  Outcome Measures
  Hide All Outcome Measures

1.  Primary:   High Mobility Group Box-1 (HMGB1)Levels at Baseline and 6 Months   [ Time Frame: baseline and 6-month follow-up ]

Measure Type Primary
Measure Title High Mobility Group Box-1 (HMGB1)Levels at Baseline and 6 Months
Measure Description High mobility group box-1 (HMGB1) is a ubiquitous nuclear protein, constitutively expressed in quiescent cells, where it is involved in several cellular functions, including determination of nucleosomal structure and stability, and binding of transcription factors to DNA sequences. HMGB1 has been recently recognized as a critical mediator of inflammatory processes: the passive release of this protein from necrotic or damaged cells represents an effective stimulus triggering the inflammatory response.
Time Frame baseline and 6-month follow-up  
Safety Issue No  

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Exercise Training Group Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program
Control Group Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program.

Measured Values
    Exercise Training Group     Control Group  
Number of Participants Analyzed  
[units: participants]
  37     38  
High Mobility Group Box-1 (HMGB1)Levels at Baseline and 6 Months  
[units: ng/ml]
Mean ± Standard Deviation
   
Baseline     27.6  ± 27.8     24.5  ± 18.6  
6 months     11.7  ± 7.0     20.5  ± 15.6  


Statistical Analysis 1 for High Mobility Group Box-1 (HMGB1)Levels at Baseline and 6 Months
Groups [1] All groups
Method [2] t-test, 2 sided
P Value [3] <0.05
[1] Additional details about the analysis, such as null hypothesis and power calculation:
  Sample size determination was based on a t-test assuming a normal distribution with non-equal variance with the mean and standard deviation for the experimental group (postinfarction patients) of HMGB1 levels equal to 15 ± 7 and 2 ± 1 ng/dl for the control group derived from a previous study, respectively. The required sample size was calculated to be 30 subjects per group to detect on the size of one SD with α value of 0.05 (two-sided) and power (1 – β) of 0.8.
[2] Other relevant information, such as adjustments or degrees of freedom:
  No text entered.
[3] Additional information, such as whether or not the p-value is adjusted for multiple comparisons and the a priori threshold for statistical significance:
  No text entered.



2.  Secondary:   Peak Oxygen Consumption (VO2peak) at Baseline and 6 Months   [ Time Frame: Baseline and 6-month follow-up ]

Measure Type Secondary
Measure Title Peak Oxygen Consumption (VO2peak) at Baseline and 6 Months
Measure Description Oxygen consumption at peak exercise stress testing (VO2peak) was obtained breath-by-breath with use of a computerized metabolic cart. VO2peak was recorded as the mean value of VO2 during the last 20 s of the test and expressed in millilitres per kilogram per minute.
Time Frame Baseline and 6-month follow-up  
Safety Issue No  

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
intention to treat (ITT) analysis

Reporting Groups
  Description
Exercise Training Group Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program
Control Group Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program.

Measured Values
    Exercise Training Group     Control Group  
Number of Participants Analyzed  
[units: participants]
  37     38  
Peak Oxygen Consumption (VO2peak) at Baseline and 6 Months  
[units: ml/kg/min]
Mean ± Standard Deviation
   
baseline     16.4  ± 1.5     16.7  ± 2.2  
6 months     21.0  ± 2.4     16.3  ± 1.8  


Statistical Analysis 1 for Peak Oxygen Consumption (VO2peak) at Baseline and 6 Months
Groups [1] All groups
Method [2] t-test, 2 sided
P Value [3] <0.05
[1] Additional details about the analysis, such as null hypothesis and power calculation:
  No text entered.
[2] Other relevant information, such as adjustments or degrees of freedom:
  No text entered.
[3] Additional information, such as whether or not the p-value is adjusted for multiple comparisons and the a priori threshold for statistical significance:
  No text entered.



3.  Other Pre-specified:   Heart Rate Recovery at Baseline and 6 Months   [ Time Frame: baseline and 6 month follow-up ]

Measure Type Other Pre-specified
Measure Title Heart Rate Recovery at Baseline and 6 Months
Measure Description

The autonomic nervous system (ANS) is the part of the peripheral nervous system that acts as a control system functioning largely below the level of consciousness, and controls visceral functions. It is subdivided into two subsystems: the parasympathetic (vagal) and sympathetic nervous system.

Sympatho-vagal imbalance is evaluated by post-exercise Heart Rate Recovery (HRR), defined as the fall in heart rate during the first minute after exercise (beats/min). HRR is a marker of vagal tone which is a powerful predictor of all-cause mortality in patients with coronary artery disease.

Time Frame baseline and 6 month follow-up  
Safety Issue No  

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Exercise Training Group Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program
Control Group Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program.

Measured Values
    Exercise Training Group     Control Group  
Number of Participants Analyzed  
[units: participants]
  37     38  
Heart Rate Recovery at Baseline and 6 Months  
[units: beats/min]
Mean ± Standard Deviation
   
baseline     13.4  ± 1.7     13.8  ± 2.7  
6 months     19.7  ± 3.4     12.4  ± 2.5  


Statistical Analysis 1 for Heart Rate Recovery at Baseline and 6 Months
Groups [1] All groups
Method [2] t-test, 2 sided
P Value [3] <0.05
[1] Additional details about the analysis, such as null hypothesis and power calculation:
  No text entered.
[2] Other relevant information, such as adjustments or degrees of freedom:
  No text entered.
[3] Additional information, such as whether or not the p-value is adjusted for multiple comparisons and the a priori threshold for statistical significance:
  No text entered.




  Serious Adverse Events


  Other Adverse Events


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Limitations and Caveats
Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.  


Results Point of Contact:  
Name/Title: Prof. Carlo Vigorito, Director Cardiac Rehabilitation Unit, Federico II University
Organization: University of Naples Federico II
phone: +39081746 ext 2639
e-mail: vigorito@unina.it


Publications:

Publications automatically indexed to this study:

Responsible Party: Carlo Vigorito, Department of Clinical Medicine, Cardiovascular and Immunological Sciences
ClinicalTrials.gov Identifier: NCT00755131     History of Changes
Other Study ID Numbers: UNINA-15775
Study First Received: September 17, 2008
Results First Received: November 5, 2009
Last Updated: January 25, 2010
Health Authority: Italy: National Institute of Health